T-CELL LYMPHOMA

Clinical trials for T-CELL LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new T-CELL LYMPHOMA trials appear

Sign up with your email to follow new studies for T-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 9 Not yet recruiting 1 Not yet finished but already full! 1 Completed 3

Scientists test drug duo in fight against deadly blood cancer

Disease control Not yet recruiting

This is an early-stage trial to see if combining two existing drugs, azacitidine and abatacept, is safe and can shrink tumors in people with T-cell lymphoma that has come back or not responded to prior treatment. The study will involve about 20 adults to find the right dose and s…

Matched conditions: T-CELL LYMPHOMA

Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 20, 2026 14:48 UTC

T-CELL LYMPHOMA

Get alerted when new T-CELL LYMPHOMA trials appear

Scientists test drug duo in fight against deadly blood cancer